MicroPort CardioFlow Medtech Corporation announced that Alwide® Plus balloon catheter independently developed by the Company was successfully registered in Colombia. Alwide® Plus is the second-generation product of the Company's Alwide® balloon catheter, which received its registration approval from the National Medical Products Administration of the People's Republic of China on July 29, 2021 and successfully registered in Argentina in March 2022. Its key features include (i) low compliance ability enables accurate sizing; (ii) high burst pressure suits for severe calcification; and (iii) fast inflation/deflation minimizes pacing time.

Compared to the first-generation product, Alwide® Plus is designed to improve burst pressure. The Company believes Alwide® Plus can reduce the challenges in valve pre- and post-dilation during TAVI (transcatheter aortic heart valve implantation) procedures. Alwide® Plus is the third product that the Company successfully registered in Colombia after the VitaFlow LibertyTM transcatheter aortic valve implantation system, and the tip-preshaped super stiff guidewire Angelguide®, marking another solid step forward on the Company's international roadmap, and will boost the promotion and application of VitaFlow LibertyTM in Colombia.